Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial

✍ Scribed by Maurie Markman; P.Y. Liu; James Moon; Bradley J. Monk; Larry Copeland; Sharon Wilczynski; David Alberts

• Book ID: 113962039
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 307 KB
• Volume: 114
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.04.012